These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1259 related articles for article (PubMed ID: 12586796)
1. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796 [TBL] [Abstract][Full Text] [Related]
2. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. Glick JH; Young ML; Harrington D; Schilsky RL; Beck T; Neiman R; Fisher RI; Peterson BA; Oken MM J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718 [TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364 [TBL] [Abstract][Full Text] [Related]
4. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM; Colonna P J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]
5. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP. Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444 [TBL] [Abstract][Full Text] [Related]
6. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related]
7. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages? Diehl V; Fuchs M; Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996 [TBL] [Abstract][Full Text] [Related]
8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
9. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
10. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ; N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708 [TBL] [Abstract][Full Text] [Related]
11. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405 [TBL] [Abstract][Full Text] [Related]
13. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821 [TBL] [Abstract][Full Text] [Related]
17. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results. Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055 [TBL] [Abstract][Full Text] [Related]
18. Advanced Hodgkin's disease: ABVD is better, yet is not good enough! Diehl V J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791 [No Abstract] [Full Text] [Related]
19. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Khan SP; Gilchrist GS; Arndt CA; Smithson WA; Chen MG; Schomberg PJ; Matsumoto JM; O'Fallon WM Mayo Clin Proc; 1994 Oct; 69(10):949-54. PubMed ID: 7523802 [TBL] [Abstract][Full Text] [Related]
20. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Santoro A; Bonadonna G Cancer Chemother Pharmacol; 1979; 2(2):101-5. PubMed ID: 93984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]